Publication|Articles|December 2, 2025
Supplements and Featured Publications
- The Transformative Approach of TEVIMBRA® (tislelizumab-jsgr) in Managing ESCC and GC/GEJC
The Transformative Approach of TEVIMBRA® (tislelizumab-jsgr) in Managing ESCC and GC/GEJC
Advertisement
This Clinical Brief was sponsored by BeOne Medicines.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5